Financhill
Sell
46

BBIO Quote, Financials, Valuation and Earnings

Last price:
$78.23
Seasonality move :
6.35%
Day range:
$74.99 - $77.28
52-week range:
$27.32 - $78.44
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
41.19x
P/B ratio:
--
Volume:
1.3M
Avg. volume:
1.9M
1-year change:
178.75%
Market cap:
$14.7B
Revenue:
$221.9M
EPS (TTM):
-$4.19

Earnings Data

Next earnings date for BBIO
Feb 19
2026
Most recent earnings per share
-$0.95
Missed by $0.18
(Oct 29/2025)
Consensus Estimate
-$0.78
(Oct 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BBIO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $167.5M -- -- -$0.60 --
02/19/2026 Q4 $148.1M -- -- -$0.62 --
10/29/2025 Q3 $106.1M $120.7M -$0.95 -$0.78 -$0.18
08/05/2025 Q2 $88.8M $110.6M -$0.95 -$0.61 -$0.35
04/29/2025 Q1 $57.7M $116.6M -$0.88 -$1.00 $0.12
02/20/2025 Q4 $4M $5.9M -$1.40 -$1.09 -$0.31
11/12/2024 Q3 $3.4M $2.7M -$0.86 -$0.86 $0.00
08/01/2024 Q2 $4.5M $2.2M -$0.39 -$0.94 $0.55
05/02/2024 Q1 $83.8M $211.1M -$0.20 -$0.54 $0.35
02/22/2024 Q4 $3.8M $1.7M -$0.96 -$0.80 -$0.17
11/02/2023 Q3 -- $4.1M -$1.08 -- --
08/03/2023 Q2 -- $1.6M -$0.98 -- --
05/04/2023 Q1 -- $1.8M -$0.92 -- --
02/23/2023 Q4 -- $1.9M -$0.92 -- --
11/03/2022 Q3 -- $338K -$0.93 -- --
08/04/2022 Q2 -- $73.7M -$0.07 -- --
05/05/2022 Q1 -- $1.7M -$1.35 -- --
02/24/2022 Q4 -- $12.9M -$1.01 -- --
11/04/2021 Q3 -- $2.3M -$1.06 -- --
08/05/2021 Q2 -- $54M -$0.66 -- --
05/06/2021 Q1 -- $462K -$1.18 -- --
02/25/2021 Q4 -- $122K -$1.01 -- --
11/05/2020 Q3 -- $8.1M -$0.98 -- --
08/11/2020 Q2 -- -- -$1.03 -- --
05/13/2020 Q1 -- -- -$0.78 -- --
03/02/2020 Q4 -- $13.8M -$0.62 -- --
11/07/2019 Q3 -- $26.7M -$0.51 -- --
08/14/2019 Q2 -- -- -$0.71 -- --
03/31/2019 Q1 -- -- -$0.50 -- --
12/31/2018 Q4 -- -- -$0.42 -- --
09/30/2018 Q3 -- -- -$0.52 -- --
06/30/2018 Q2 -- -- -$0.26 -- --
03/31/2018 Q1 -- -- -$0.30 -- --

BridgeBio Pharma, Inc. Earnings Questions

  • How Much did BridgeBio Pharma, Inc. Generate in Revenue Last Quarter?

    BridgeBio Pharma, Inc. reported $120.7M worth of top line sales in its most recent quarter.

  • Did BridgeBio Pharma, Inc. Beat Earnings Last Quarter?

    BridgeBio Pharma, Inc. announced earnings per share of -$0.95 which represents a miss of analyst forecast a -$0.78 per share.

  • Is BridgeBio Pharma, Inc. Profitable?

    BridgeBio Pharma, Inc. reported $113.4M that represents $0.59 per share over the last quarter.

  • What is the Analyst Consensus for BridgeBio Pharma, Inc. EPS Next Year?

    BridgeBio Pharma, Inc.'s earnings are forecast to decrease from -$2.88 per share to -$3.19 per share next year representing a decrease of -10.79%.

  • When is BridgeBio Pharma, Inc.'s Earnings Date?

    BridgeBio Pharma, Inc.'s next earnings date is February 19, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
45
CTEV alert for Jan 2

Claritev Corp. [CTEV] is down 20.7% over the past day.

Sell
47
ASTS alert for Jan 2

AST Spacemobile, Inc. [ASTS] is up 14.94% over the past day.

Sell
45
BIDU alert for Jan 2

Baidu, Inc. [BIDU] is up 15.01% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock